12-121921631-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The ENST00000288912.9(CFAP251):c.326G>A(p.Arg109His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,930 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000288912.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP251 | NM_144668.6 | c.326G>A | p.Arg109His | missense_variant | 2/22 | ENST00000288912.9 | NP_653269.3 | |
CFAP251 | NM_001178003.2 | c.326G>A | p.Arg109His | missense_variant | 2/18 | NP_001171474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP251 | ENST00000288912.9 | c.326G>A | p.Arg109His | missense_variant | 2/22 | 1 | NM_144668.6 | ENSP00000288912 | ||
CFAP251 | ENST00000397454.2 | c.326G>A | p.Arg109His | missense_variant | 2/18 | 1 | ENSP00000380595 | P1 | ||
CFAP251 | ENST00000540779.1 | n.224G>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000403 AC: 10AN: 248106Hom.: 1 AF XY: 0.0000520 AC XY: 7AN XY: 134598
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460636Hom.: 3 Cov.: 37 AF XY: 0.0000275 AC XY: 20AN XY: 726562
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152294Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.326G>A (p.R109H) alteration is located in exon 2 (coding exon 1) of the WDR66 gene. This alteration results from a G to A substitution at nucleotide position 326, causing the arginine (R) at amino acid position 109 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at